XML 42 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHAREHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2013
SHAREHOLDERS' EQUITY [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 8:-
SHAREHOLDERS' EQUITY

 
  a.
On April 24, 2013, the Company entered into a private placement transaction (the "2013 PIPE"). Under the PIPE investment, the Company issued 1,239,639 Ordinary Shares to investors (investors in the 2013 PIPE included certain existing shareholders) at an aggregate purchase price of $ 3,459 or $ 2.79 per Ordinary Share. The Company also issued to the investors warrants to purchase one Ordinary Share for every three Ordinary Shares purchased by each investor (up to 413,213 shares) for an exercise price of $ 3.49 per Ordinary Share. The warrants are exercisable for three years from the closing of the 2013 PIPE.  As of June 30, 2013, no warrants were exercised.

 
  b.
On April 3, 2013, the Company approved a new Share Option Plan (the "2013 Share Option Plan"). The 2013 Share Option Plan grants options to purchase Ordinary Shares. These options are granted pursuant to the 2013 Share Option Plan for the purpose of providing incentives to employees, directors, consultants and contractors of the Company.

 
  c.
The following is a summary of the Company's stock options activity for the six months ended June 30, 2013:

   
Number of options(in thousands)
   
Weighted-average exercise price
   
Weighted- average remaining contractual term
 (in years)
   
Aggregate intrinsic value
 
                         
Outstanding at December 31, 2012
    1,034,205       4.0       4.0     $ 529  
Granted
    210,750       3.65                  
Exercised
    (41,845 )     1.02                  
Expired & Forfeited
    (39,750 )     6.11                  
                                 
Outstanding at June 30, 2013
    1,163,360       3.98       4.49     $ 792  
                                 
Exercisable at June 30, 2013
    827,052       4.17       3.38     $ 744  
                                 
    Vested and expected to vest at June  30, 3013
    1,163,360       3.98       4.49     $ 792  

The weighted average fair value of options granted during the six months ended June 30, 2013 was $ 1.69.
 
The following table shows the total stock-based compensation expense included in the interim condensed consolidated statements of operations:

   
Six months ended
June 30,
 
   
2013
   
2012
 
   
Unaudited
 
             
Cost of sales
  $ 5     $ 9  
Research and development
    86       98  
Selling and marketing
    61       92  
General and administrative
    145       72  
                 
    $ 297     $ 271